Althea Group Holdings Ltd (ASX:AGH) – a company focused on the manufacturing and retail of cannabis products – has sold its MyAccess Clinics business in the United Kingdom and Ireland to Montu UK Ltd for $1 million as part of a streamlining plan.
MyAccess provided medical cannabis treatments to help patients dealing with chronic pain, mental health and sleep conditions.
The sale is expected to allow Althea to achieve operating cost savings of around $1.5 million, as well as annualised cost savings of $4 million, previously announced in May.
On top of that, the company will now be able to concentrate more on expansion of its North American operations, particularly targeting the cannabis beverage sector through Peak Processing Solutions – its recreational cannabis business whose products are marketed to retail stores.
Althea CEO Joshua Fegan said the decision would boost the company’s ability to grow in North America in particular.
“The completion of this sale marks a significant step in AGH’s strategy to streamline our operations and sharpen our focus on high-growth opportunities,” he said.
“By divesting MyAccess Clinics, we are better positioned to accelerate our North American expansion, particularly in the cannabis beverages market through Peak Processing Solutions.”
Althea has been trading at 4.3 cents.
Join the discussion: See what HotCopper users are saying about Althea and be part of the conversations that move the markets.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。